Literature DB >> 19749991

Impact of bipolar disorder on the family: utilization and cost of health care resources.

Mary Lou Chatterton, Xiongkan Ke, Barbara Edelman Lewis, Krithika Rajagopalan, Arthur Lazarus.   

Abstract

OBJECTIVE: Our retrospective analysis compared costs and patterns of health care utilization by families that included a member with bipolar disorder ("bipolar families") and by families without serious psychiatric disease ("control families").
METHODS: We used the MarketScan Commercial Claims and Encounters Database covering January 1998 through December 2002. International Classification of Diseases (ICD-9-CM) codes were used to identify individuals with bipolar disorder and link them to their family members. Bipolar families were matched in a ratio of 1:3 to families without a serious mental illness. We calculated and statistically compared the mean annual use of resources and health care costs for each group, including the individual with bipolar disorder. We used a multivariate model to test the effect of demographic and health care variables on the impact of total health care expenditures.
RESULTS: Families with a member with bipolar disorder (n = 43,448), compared with matched families (n = 122,769), made significantly more outpatient physician visits (24 vs. eight; P < 0.001), more inpatient hospital stays (1 vs. 0.3; P < 0.001), and more prescription medications (24 vs. 7.8; P < 0.001). Total annual health care costs were more than three-fold higher for bipolar families ($4,664), compared with matched families ($1,376) (P < 0.001). The multivariate model controlled for family size and comorbidities, indicating significantly higher total health care costs for families with one or more persons with bipolar disorder than for matched families without serious mental illness.
CONCLUSION: These results indicate that bipolar disorder has a significant financial impact on families in addition to the individual with the diagnosis.

Entities:  

Year:  2008        PMID: 19749991      PMCID: PMC2730065     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  31 in total

1.  The economic burden of affective disorders.

Authors:  D P Rice; L S Miller
Journal:  Adv Health Econ Health Serv Res       Date:  1993

2.  Health care utilization and costs among patients treated for bipolar disorder in an insured population.

Authors:  G E Simon; J Unützer
Journal:  Psychiatr Serv       Date:  1999-10       Impact factor: 3.084

3.  The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

Authors:  C E Begley; J F Annegers; A C Swann; C Lewis; S Coan; W B Schnapp; L Bryant-Comstock
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 4.  Substance abuse in bipolar disorder.

Authors:  F Cassidy; E P Ahearn; B J Carroll
Journal:  Bipolar Disord       Date:  2001-08       Impact factor: 6.744

5.  Subjective burden among family members of mentally ill adults: relation to stress, coping, and adaptation.

Authors:  P Solomon; J Draine
Journal:  Am J Orthopsychiatry       Date:  1995-07

6.  Predictors of burden and infectious illness in schizophrenia caregivers.

Authors:  D G Dyck; R Short; P P Vitaliano
Journal:  Psychosom Med       Date:  1999 Jul-Aug       Impact factor: 4.312

7.  Suicidal ideation and attempts in bipolar I and II disorders.

Authors:  Hanna Valtonen; Kirsi Suominen; Outi Mantere; Sami Leppämäki; Petri Arvilommi; Erkki T Isometsä
Journal:  J Clin Psychiatry       Date:  2005-11       Impact factor: 4.384

Review 8.  Recognition and diagnosis of bipolar disorder.

Authors:  Robert M A Hirschfeld; Lana A Vornik
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

9.  The health of primary caregivers of children with cerebral palsy: how does it compare with that of other Canadian caregivers?

Authors:  Jamie C Brehaut; Dafna E Kohen; Parminder Raina; Stephen D Walter; Dianne J Russell; Marilyn Swinton; Maureen O'Donnell; Peter Rosenbaum
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

10.  The family impact and costs of migraine.

Authors:  Paul E Stang; William H Crown; Rich Bizier; Mary Lou Chatterton; Richard White
Journal:  Am J Manag Care       Date:  2004-05       Impact factor: 2.229

View more
  4 in total

1.  Meta-analysis demonstrates lack of association of the GSK3B -50C/T polymorphism with risk of bipolar disorder.

Authors:  Guodi Chen; Jun Tang; Guangwei Yu; Yiping Chen; Liancong Wang; Yao Zhang
Journal:  Mol Biol Rep       Date:  2014-06-15       Impact factor: 2.316

Review 2.  Quetiapine: a pharmacoeconomic review of its use in bipolar disorder.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2012-07-01       Impact factor: 4.981

3.  Exome sequencing of a large family identifies potential candidate genes contributing risk to bipolar disorder.

Authors:  Tianxiao Zhang; Liping Hou; David T Chen; Francis J McMahon; Jen-Chyong Wang; John P Rice
Journal:  Gene       Date:  2017-12-14       Impact factor: 3.688

Review 4.  Improving the Assessment Process of Family Functioning in Adult Bipolar Disorders: A PRISMA Systematic Review.

Authors:  Caroline Munuera; Philippe Compagnone; Mathilde M Husky; Paul Lebourleux; Fanny Petit; Katia M'bailara
Journal:  J Clin Med       Date:  2022-02-05       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.